TP53 and neoplasm: Pathology revealed strong ACTH-positive immunostaining in 90% of the cells and a Ki-67 labeling index (LI) of greater than 10%, and weak immunoreactivity for p53 was observed in almost 5% of tumor cells (Figure 7).